Related Experiment Video

Updated: Apr 21, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI

Kai-Bin Song1, Wen-Juan Liu2, Shen-Shan Jia1

  • 1Department of Head and Neck Surgery, Third Affiliated Hospital of Harbin Medical University Harbin 150081, Heilongjiang, China.

International Journal of Clinical and Experimental Medicine
|October 31, 2014
PubMed

Insights

MicroRNA-219 (miR-219) is downregulated in tongue squamous cell carcinoma (TSCC). Restoring miR-219 inhibits TSCC growth and metastasis by targeting PRKCI, offering a potential treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tongue squamous cell carcinoma (TSCC) is a prevalent oral cancer.
  • MicroRNAs (miRNAs) are increasingly recognized for their roles in cancer development.
  • The specific function of miR-219 in TSCC remains largely unexplored.

Purpose of the Study:

  • To investigate the role of miR-219 in the progression of TSCC.
  • To identify potential molecular targets of miR-219 in TSCC.
  • To evaluate miR-219 as a therapeutic target for TSCC.

Main Methods:

  • Quantitative real-time PCR to assess miR-219 expression levels in TSCC tissues and cell lines.
  • Cell proliferation, colony formation, migration, and invasion assays to evaluate the functional impact of miR-219.
  • Western blotting and luciferase reporter assays to confirm PRKCI as a direct target of miR-219.
  • Correlation analysis between miR-219 and PRKCI expression in patient tissues.

Main Results:

  • miR-219 was significantly downregulated in TSCC tissues and cell lines compared to normal controls.
  • Overexpression of miR-219 suppressed TSCC cell proliferation, colony formation, migration, and invasion.
  • Protein kinase CI (PRKCI) was identified as a direct target of miR-219.
  • PRKCI overexpression counteracted the tumor-suppressive effects of miR-219, and PRKCI expression was inversely correlated with miR-219 levels in TSCC tissues.

Conclusions:

  • miR-219 functions as a tumor suppressor in TSCC by targeting PRKCI.
  • The miR-219/PRKCI axis plays a critical role in TSCC growth and metastasis.
  • miR-219 holds potential as a therapeutic target for tongue squamous cell carcinoma treatment.
Keywords:
PRKCITSCCgrowthmetastasismiR-219

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K